X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare RASOYA PROTEINS with GSK Consumer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RASOYA PROTEINS vs GSK CONSUMER - Comparison Results

GSK CONSUMER 
   Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RASOYA PROTEINS GSK CONSUMER RASOYA PROTEINS/
GSK CONSUMER
 
P/E (TTM) x 2.6 37.3 6.9% View Chart
P/BV x 0.6 9.1 6.4% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 RASOYA PROTEINS   GSK CONSUMER
EQUITY SHARE DATA
    RASOYA PROTEINS
Mar-16
GSK CONSUMER
Mar-18
RASOYA PROTEINS/
GSK CONSUMER
5-Yr Chart
Click to enlarge
High Rs16,793 0.0%   
Low RsNA4,919 0.0%   
Sales per share (Unadj.) Rs0.41,026.3 0.0%  
Earnings per share (Unadj.) Rs-2.3166.5 -1.4%  
Cash flow per share (Unadj.) Rs-2.2181.8 -1.2%  
Dividends per share (Unadj.) Rs075.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs0.3828.6 0.0%  
Shares outstanding (eoy) m1,708.9342.06 4,063.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.05.7 17.6%   
Avg P/E ratio x-0.235.2 -0.6%  
P/CF ratio (eoy) x-0.232.2 -0.6%  
Price / Book Value ratio x1.67.1 23.2%  
Dividend payout %045.1 0.0%   
Avg Mkt Cap Rs m769246,284 0.3%   
No. of employees `0000.14.0 3.7%   
Total wages/salary Rs m595,277 1.1%   
Avg. sales/employee Rs Th5,246.610,837.3 48.4%   
Avg. wages/employee Rs Th400.71,325.0 30.2%   
Avg. net profit/employee Rs Th-26,690.41,757.7 -1,518.5%   
INCOME DATA
Net Sales Rs m76643,165 1.8%  
Other income Rs m72,574 0.3%   
Total revenues Rs m77345,739 1.7%   
Gross profit Rs m-2,9178,834 -33.0%  
Depreciation Rs m121644 18.8%   
Interest Rs m4520 220.2%   
Profit before tax Rs m-3,07510,744 -28.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-9280-   
Tax Rs m-1073,743 -2.9%   
Profit after tax Rs m-3,8977,001 -55.7%  
Gross profit margin %-380.720.5 -1,860.5%  
Effective tax rate %3.534.8 10.0%   
Net profit margin %-508.716.2 -3,136.5%  
BALANCE SHEET DATA
Current assets Rs m11145,620 0.2%   
Current liabilities Rs m2,89217,426 16.6%   
Net working cap to sales %-363.165.3 -555.9%  
Current ratio x02.6 1.5%  
Inventory Days Days2135 59.9%  
Debtors Days Days1524 63.1%  
Net fixed assets Rs m1,8645,138 36.3%   
Share capital Rs m1,709421 406.3%   
"Free" reserves Rs m-1,24934,431 -3.6%   
Net worth Rs m47034,851 1.3%   
Long term debt Rs m9600-   
Total assets Rs m6,24954,127 11.5%  
Interest coverage x-67.8530.2 -12.8%   
Debt to equity ratio x2.00-  
Sales to assets ratio x0.10.8 15.4%   
Return on assets %-61.613.0 -475.2%  
Return on equity %-829.520.1 -4,129.1%  
Return on capital %-276.930.9 -896.6%  
Exports to sales %5.40-   
Imports to sales %00-   
Exports (fob) Rs m41NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m413,014 1.4%   
Fx outflow Rs m0186 0.1%   
Net fx Rs m412,828 1.5%   
CASH FLOW
From Operations Rs m407,230 0.5%  
From Investments Rs mNA-4,465 0.0%  
From Financial Activity Rs m-42-3,634 1.2%  
Net Cashflow Rs m-3-868 0.3%  

Share Holding

Indian Promoters % 31.7 0.0 -  
Foreign collaborators % 0.0 72.5 -  
Indian inst/Mut Fund % 0.0 0.8 -  
FIIs % 3.7 12.0 30.8%  
ADR/GDR % 26.7 0.0 -  
Free float % 37.9 14.8 256.1%  
Shareholders   4,554 26,457 17.2%  
Pledged promoter(s) holding % 41.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RASOYA PROTEINS With:   KRBL LIMITED  GODFREY PHILLIPS  ITC LTD  TATA COFFEE  GOODRICKE  

Compare RASOYA PROTEINS With:   COCA COLA (US)  NESTLE (Switz.)  TIGER BRANDS (S. Africa)  AVI LTD. (S. Africa)  



Today's Market

Sensex Ends 190 Points Higher; Consumer Durable and Healthcare Stocks Witness Buying(Closing)

After trimming sharp losses in the afternoon session, Indian share markets continued to witness buying interest and ended the day on a positive note.

Related Views on News

GSK CONSUMER Announces Quarterly Results (2QFY19); Net Profit Up 43.2% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, GSK CONSUMER has posted a net profit of Rs 3 bn (up 43.2% YoY). Sales on the other hand came in at Rs 13 bn (up 14.0% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (1QFY19); Net Profit Up 51.6% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 51.6% YoY). Sales on the other hand came in at Rs 11 bn (up 5.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

GSK CONSUMER Announces Quarterly Results (4QFY18); Net Profit Up 20.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 20.4% YoY). Sales on the other hand came in at Rs 12 bn (down 2.4% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

RASOYA PROTEINS SHARE PRICE


Nov 5, 2018 (Close)

TRACK RASOYA PROTEINS

  • Track your investment in RASOYA PROTEINS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON RASOYA PROTEINS

RASOYA PROTEINS 8-QTR ANALYSIS

COMPARE RASOYA PROTEINS WITH

MARKET STATS